GHK-Cu has early evidence for eyebrow growth, but it isn’t an established treatment for a thinning scalp or receding hairline. A small 2026 study found an improvement in eyebrow hair count and thickness. Other often-cited hair studies tested a different copper peptide or a different formula. Those details matter if you’re deciding what a “hair growth” claim really promises.
If copper peptides keep appearing in your feed, the useful question is where the result happened: in a lab, on eyebrows, or on the scalp of someone with your type of hair loss.
What is GHK-Cu doing in hair products?
GHK-Cu is a short peptide bound to copper. You may already know it from copper-peptide skincare, where researchers have studied particular creams and serums for changes in skin appearance. Hair growth is a separate outcome; smoother skin doesn’t demonstrate a fuller hairline.
“Copper peptides” also covers more than one ingredient. GHK-Cu and AHK-Cu are different peptides, even though the names look almost identical. That one-letter difference becomes important when someone links a paper as proof that their serum works.
Can GHK-Cu grow eyebrows or scalp hair?
A 2026 conference report on GHK-Cu serum studied 18 adults aged 18–40 with sparse eyebrows. Each person used the test serum on one eyebrow and the vehicle—the serum base without GHK-Cu—on the other for 12 weeks. The treated side had better hair-count and hair-diameter results at the end.
That’s an encouraging early result for the specific eyebrow serum. It was also a small study, and it didn’t test scalp hair loss. It can’t tell you whether GHK-Cu will fill in temples, reverse a receding hairline, or keep working over years. An eyebrow finding shouldn’t become a promise about every kind of thinning hair.
There is some human scalp research involving GHK, but the formulation matters here too. A six-month study in 45 men with pattern hair loss tested a complex of GHK and 5-aminolevulinic acid called ALAVAX. It reported a hair-count benefit in one comparison with placebo, without a significant difference in hair thickness between groups. That combination wasn’t a GHK-Cu serum, so its results don’t establish what a copper-peptide product will do.

Why do so many claims link to a lab study?
A frequently cited 2007 copper-peptide experiment used AHK-Cu. Researchers studied isolated human hair follicles and cells outside the body. They observed follicle elongation and cell proliferation.
“Human hair follicles” can sound like people grew more hair during treatment. Here, it means the lab material came from humans. The experiment gives researchers a reason to investigate; it doesn’t show that applying GHK-Cu to your scalp treats pattern hair loss.
When checking a claim, look for three matches: the same ingredient, the same product or delivery method, and the same kind of hair loss. A mismatch doesn’t make a study worthless. It changes the question it can answer.
Is GHK-Cu an alternative to minoxidil?
The studies above don’t establish it as an equivalent substitute. The American Academy of Dermatology’s treatment guidance describes minoxidil as an option with evidence for certain forms of hair loss and emphasizes finding the cause first. Sudden shedding, breakage, and gradual pattern thinning aren’t automatically the same problem.
Injections aren’t a proven shortcut either. The FDA identifies limited human safety data and potential immune-reaction risks for injected GHK-Cu. A topical eyebrow study can’t establish an injection’s benefit or safety.
For your own comparisons, separate more hairs, thicker strands, and a fuller-looking photo. Use similar lighting, hair length, and camera angles, and keep track of other treatments that changed. A better photo alone can’t tell you which product helped—or whether new hair grew at all.
